Europe Formulation CDMO Services Market was valued at USD 10.3 Billion in 2022 and is projected to reach USD 16.3 Billion by 2030, growing at a CAGR of 7.4% from 2024 to 2030.
The Europe Formulation CDMO Services Market is rapidly growing as pharmaceutical companies and other industries seek to optimize their manufacturing processes. The demand for Contract Development and Manufacturing Organizations (CDMOs) has surged as businesses aim to reduce costs, accelerate product development, and meet evolving market needs. These organizations provide essential services in drug formulation, development, and manufacturing, making them a vital part of the pharmaceutical and biotech industries.
In Europe, the formulation CDMO services market is driven by several factors, including the increasing complexity of drug formulations and the need for high-quality, cost-effective production capabilities. Many pharmaceutical companies, particularly in the generics and biosimilars segments, are relying on CDMOs for assistance in the formulation process, which involves creating the final dosage form of a drug, ensuring its stability, and meeting regulatory requirements. CDMOs provide essential services like active pharmaceutical ingredient (API) sourcing, formulation development, stability testing, and clinical trial material production.
Industries are increasingly seeking tailored solutions to meet their specific needs. For instance, pharmaceutical companies may look for CDMOs that specialize in a particular type of formulation, such as injectables, oral solids, or biologics. The demand for specialized services is rising due to the growing complexity of drug formulations, especially with the rise of personalized medicine and biologics. The ability to address unique challenges—such as scaling up production, ensuring regulatory compliance, and maintaining cost efficiency—is a key factor driving the growth of the formulation CDMO services market in Europe.
Additionally, the need for rapid market access and faster drug development timelines has intensified the demand for formulation CDMO services. By outsourcing manufacturing, pharmaceutical companies can focus on their core activities, such as research and marketing, while relying on CDMOs to manage the production process efficiently. The formulation CDMO services market also benefits from the increasing number of small and medium-sized pharmaceutical firms that are entering the market and require external support for drug development and manufacturing.
As a result, Europe is expected to continue to be a significant hub for formulation CDMO services, as the demand for innovative and high-quality pharmaceutical products remains strong. The evolution of drug development, regulatory landscapes, and manufacturing technologies will continue to shape the future of this market.
Get an In-Depth Research Analysis of the Europe Formulation CDMO Services Market Size And Forecast [2025-2032]
Â
Medicilon
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Zhejiang Jiuzhou Pharmaceutical
Sinopep
Frontier Biotechnologies
JYMed
Chengdu Shengnuo Biotechnology
Shanghai Soho-Yiming Pharmaceuticals
Chinese Peptide Company
Ambio Pharmaceuticals
Zhejiang Peptites Biotech
STA Pharmaceutical
Zhejiang Langhua Pharmaceutical
Viva Biotech
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Formulation CDMO Services Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Formulation CDMO Services Market
Solid Formulations
Liquid Formulations
Semi-Solid Formulations
Injectable Formulations
Specialty Formulations
Pharmaceuticals
Biotechnology
Nutraceuticals
Cosmetics and Personal Care
Food and Beverage
Contract Development
Contract Manufacturing
Analytical Services
Stability Testing
Regulatory Services
Small Molecules
Large Molecules
Biologics
Oral Dosage Forms
Topical Dosage Forms
Preclinical
Clinical
Commercial
Scale-Up Services
Custom Manufacturing
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
For More Information or Query, Visit @ Formulation CDMO Services Market Research Analysis
1. Introduction of the Europe Formulation CDMO Services Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Formulation CDMO Services Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Formulation CDMO Services Market, By Type
6. Europe Formulation CDMO Services Market, By Application
7. Europe Formulation CDMO Services Market, By Geography
Europe
Germany
UK
France
8. Europe Formulation CDMO Services Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/